Recombinetics (United States)
Recombinetics is a St. Paul, Minnesota-based bio-engineering company. The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the CEO. In November 2024, Recombinetics filed for Chapter 11 bankruptcy protection. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Recombinetics (United States), United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
75%
Total
Publications
182
Total Open
Publications
136
Total
Citations
6.8K
Open Access
Percentage
75%
Total
Publications
182
Total Open
Publications
136
Total
Citations
6.8K
Breakdown
Publisher Open
22%
Both
45%
Other Platform Open
6%
Closed
27%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 50%
57
Hybrid 33%
37
No Guarantees 17%
19
Other Platform Open
Domain 88%
80
Institution 40%
36
Other Internet 18%
16
Public 4%
4
Preprint 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 79 |
DOI | Other Internet | 14 |
Università Cattolica del Sacro Cuore - PubliCatt | Institution | 8 |
Europe PMC | Domain | 8 |
São Paulo State University - UNESP Institutional Repository | Institution | 7 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 6 |
Figshare | Public | 5 |
Elsevier - Scopus | Institution | 5 |
University of Bern - Bern Open Repository and Information System | Institution | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |